The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.
To order this 320+ page report, which features 45+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:
§ Target Disease Indication
- Breast Cancer
- Chronic Lymphocytic Leukemia
- Colorectal Cancer
- Head and Neck Cancer
- Lung Cancer
- Lupus Nephritis
- Melanoma
- Multiple Myeloma
- Primary Sjögren's Syndrome
- Others
§ Target Immune Checkpoint
- B7-H3
- CD38
- CD40
- CD47
- Others
§ Mechanism of Action
- Inhibitory
- Stimulatory
§ Therapeutic Modality
- Monoclonal Antibody
- Small Molecule
§ Type of Therapy
- Monotherapy
- Combination Therapy
§ Route of Administration
- Intravenous
- Subcutaneous
- Others
§ Key Geographical Regions
- North America
- Europe
- Asia-Pacific and the Rest of the World
The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
§ Advanced Accelerator Applications
§ Belgian Nuclear Research Center (SCK•CEN)
§ Cardinal Health
§ China Isotope & Radiation Corporation
§ Curium Pharma
§ DuChemBio
§ Eckert & Ziegler
§ Eczacibasi-Monrol
§ GE Healthcare
§ Jubilant DraxImage
§ Lantheus Medical Imaging
§ Nihon Medi-Physics
§ Nordion
§ PETNET Solutions
§ SinoTau Pharmaceuticals
§ SOFIE
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis
10. Partnerships and Collaborations
11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
